0001209191-16-139572.txt : 20160901 0001209191-16-139572.hdr.sgml : 20160901 20160901200049 ACCESSION NUMBER: 0001209191-16-139572 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160830 FILED AS OF DATE: 20160901 DATE AS OF CHANGE: 20160901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRYANT DOUGLAS C CENTRAL INDEX KEY: 0001406652 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 161866852 MAIL ADDRESS: STREET 1: C/O QUIDEL CORPORATION STREET 2: 12544 HIGH BLUFF DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-08-30 0 0000353569 QUIDEL CORP /DE/ QDEL 0001406652 BRYANT DOUGLAS C 12544 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130 1 1 0 0 President & CEO Common Stock 2016-08-30 4 M 0 2832 8.50 A 276843 D Common Stock 2016-08-30 4 S 0 2832 22.00 D 274011 D Non-Qualified Stock Options 8.50 2016-08-30 4 M 0 2832 0.00 D 2013-04-10 2019-04-10 Common Stock 2832 202380 D All of the transactions reported in this Form 4 were effected pursuant to a pre-established 10b5-1 trading plan. Robert J. Bujarski, attorney-in-fact for Douglas C. Bryant 2016-09-01